medigraphic.com
ENGLISH

Revista Cubana de Genética Comunitaria

ISSN 2070-8718 (Impreso)
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2013, Número 1

Siguiente >>

Rev Cub Gen 2013; 7 (1)


Genoma y ambiente en la génesis de la obesidad

Hernández FRA
Texto completo Cómo citar este artículo Artículos similares

Idioma: Español
Referencias bibliográficas: 22
Paginas: 5-11
Archivo PDF: 638.28 Kb.


PALABRAS CLAVE

obesidad, control de apetito, peso corporal, leptina, receptor de leptina, propiomelanocortina, prohormona convertasa, receptor 4 de melanocortina.

RESUMEN

En las últimas décadas la obesidad se ha convertido en una epidemia mundial. Representa un factor de riesgo para condiciones con una alta mortalidad, como enfermedades cardiovasculares, diabetes y cáncer. Este artículo pretende poner al día las causas principales de su origen así como la relación entre el ambiente y el genoma en su desarrollo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ahima RS. Obesity: Much Silence Makes a Mighty Noise. Gastroenterology. 2007;132:2085-2086.

  2. Tolle V, Low MJ. In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice. Diabetes. 2008;57:86-94.

  3. Coll AP, Farooqi IS, O’Rahilly S. The Hormonal Control of Food Intake. Cell. 2007;129:251-262.

  4. Wren AM, Bloom SR. Gut Hormones and Appetite Control. Gastroenterology. 2007;132:2116-2130.

  5. Jacquemond S, Reymond A, Zufferey F, Harewood L, Walters R G, Kutalik Z, et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 11p11.2 locus. Nature. 2011;478:97-102.

  6. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The Epidemiology of Obesity. Gastroenterology. 2007;132:2087-2102.

  7. Niswender, KD, Beech BM. Obesity: Increasing Awareness of Novel Environmental Factors. Diabetes. 2008;57:1786-1787.

  8. Friedman JM. A war on obesity, not the obese. Science. 2003;299:856-858.

  9. Isse N, Ogawa Y, Tamura N, Masuzaki H, Mori K, Okazaki T, et al. Structural organization and chromosomal assignment of the human obese gene. J Biol Chem. 1995;270:27728-27733.

  10. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998;18:213-215.

  11. Winick JD, Stoffel M, Friedman JM. Identification of microsatellite markers linked to the human leptin receptor gene on chromosome 1. Genomics. 1996;36:221-222.

  12. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19:155-157.

  13. Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, et al. A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3:135-140.

  14. Yeo GS, Farooqi IS, Challis BG, Jackson RS, O’Rahilly S. The role of melanocortinsignalling in the control of body weight: evidence from human and murine genetic models. QJM. 2000;93:7-14.

  15. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analices of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab. 2005;90:219-224.

  16. Holder JL, Jr, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Molec Genet. 2000;9:101-108.

  17. Faivre L, Cormier-Daire V, Lapierre JM, Colleaux L, Jacquemont S, et al. Deletion of the SIM1 gene (6q16.2) in a patient with a Prader-Willi-like phenotype. (Letter) J Med Genet. 2002;39: 594-596.

  18. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O’Rahilly S, Farooqi IS. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci. 2004;7:1187–1189.

  19. Gray J, Yeo GSH, Cox JJ, Morton J, Adlam A-L R, Keogh JM, et al. Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the Brain-Derived Neurotrophic Factor (BDNF) Gene. Diabetes. 2006;55:3366-3371.

  20. Loos, RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008;9:246-50.

  21. Wadden TA, Butryn ML, Wilson Ch. Lifestyle Modification for the Management of Obesity. Gastroenterology. 2007;132:2226-2238.

  22. Bray GA, Ryan DH. Drug Treatment of the Overweight Patient. Gastroenterology. 2007;132:2239-2252.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Gen . 2013;7

ARTíCULOS SIMILARES

CARGANDO ...